Overview
Chemicals

FUSO CHEMICAL CO.,LTD.

Fuso Chemical Co., Ltd. operates two core business segments: Life Science and Electronic Materials & Functional Chemicals. The Life Science segment manufactures and sells fruit acids (malic acid, citric acid, gluconic acid) and organic acids for food, cosmetics, detergent, and industrial applications, as well as applied products such as food quality improvers and sanitation solutions. The Electronic Materials & Functional Chemicals segment produces ultra-high-purity colloidal silica primarily used as a CMP (Chemical Mechanical Planarization) slurry abrasive for next-generation semiconductor manufacturing, along with resin additives and fine chemicals.

Market Cap
¥303B
US$1.93B
EV
¥279B
US$1.78B
Stock¥2,860▼-0.69%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
9.4
x
LTM EV/EBIT
14.8
x
LTM PER
21.1
x
LTM PBR
2.5
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▲+52.0%pt
1001
Oct 24, 25 – Oct 23, 26StockTOPIX
1Aug 10, 26Q1 FY2027/03 earnings announced
MC → EV Bridge
303BUS$1.93BMarket Cap16.0BUS$102M+ Debt38.3BUS$244M− Cash0.89BUS$5.71M− Inv. Sec.279BUS$1.78BEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
55.8US$356M'22/368.5US$437M'23/359.0US$376M'24/369.5US$443M'25/376.9US$491M'26/3
EBITDA 5Y (¥B)
19.5US$124M'22/323.3US$148M'23/318.2US$116M'24/324.5US$157M'25/329.8US$190M'26/3
Net Income 5Y (¥B)
10.9US$69.5M'22/314.1US$90.1M'23/38.34US$53.2M'24/311.6US$74.1M'25/314.3US$91.3M'26/3
Capital Structure
89%
EquityD/E 0.13xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
25.3US$161M'22/324.1US$154M0.02US$0.16M'23/332.4US$206M20.0US$128M'24/332.0US$204M20.1US$128M'25/341.7US$266M17.0US$108M'26/3
Shareholders
Top 10 hold 64.3%
1
Jusedo Co., Ltd.
15.87%
2
Teikoku Pharma Co., Ltd.
9.44%
3
The Master Trust Bank of Japan, Ltd. (Trust Account)
9.19%
4
Kunpusha Co., Ltd.
7.43%
5
Custody Bank of Japan, Ltd. (Trust Account)
6.52%
6
Osaka Small and Medium Business Investment & Consultation Co., Ltd.
4.23%
7
Teisan Co., Ltd.
3.90%
8
THE BANK OF NEW YORK MELLON 140042 (Standing Proxy: Mizuho Bank, Ltd.)
2.86%
9
Akazawa Memorial Foundation
2.84%
10
US BANK NATIONAL ASSOCIATION JP ACCTS TS (Standing Proxy: MUFG Bank, Ltd.)
2.01%
Management
12 officers
Misako FUJIOKA
Representative Director, Chairman
Jun 1988: Outside Director of the Company Mar 1999: Representative Director, Teikoku Pharma Co., Ltd. Mar 2011: President, Teikoku Pharma Co., Ltd. (current) Jun 2017: Representative Director, Chairman of the Company (current) Jun 2020: Outside Director (Audit and Supervisory Committee Member), Asahi Broadcasting Group Holdings Corporation (current)
1955-04-22
Shinichi SUGITA
Representative Director, President
Apr 1980: Joined Fujisawa Pharmaceutical Co., Ltd. (now Astellas Pharma Inc.) Apr 2005: Joined the Company Apr 2006: General Manager, Planning and Development Department, Life Science Business Division Sales and Development Headquarters Jul 2012: Executive Officer; General Manager, Electronic Materials Headquarters and Head of Kyoto Plant Feb 2019: Deputy General Manager, Administration Headquarters Jun 2019: Director; General Manager, Administration Headquarters; in charge of Innovation Promotion Office Jun 2020: Representative Director, President (current)
1955-10-05
Haruo MASUJI
Senior Managing Director; General Manager, Life Science Business Division
Apr 1990: Joined the Company Jul 2005: General Manager, Electronic Materials Sales and Development Department, Electronic Materials Business Division Feb 2008: General Manager, Electronic Materials Headquarters, Electronic Materials Business Division Jul 2008: Executive Officer Jul 2010: Senior Executive Officer; General Manager, Electronic Materials Business Division Jun 2011: Director Apr 2019: Managing Director Jun 2020: Senior Managing Director (current); in charge of Innovation Promotion Office Apr 2024: General Manager, Life Science Business Division (current)
1967-03-23
Atsushi FUJIOKA
Managing Director; General Manager, Corporate Planning Department
Nov 2019: Joined the Company Mar 2020: Director, Teikoku Pharma Co., Ltd. (current) Jul 2020: Executive Officer; General Manager, Corporate Planning Office Jun 2021: Director Apr 2024: Managing Director (current) Apr 2025: General Manager, Corporate Planning Department (current) General Manager, Business Development Department
1988-05-04
Motoki SUGIMOTO
Director; General Manager, Electronic Materials Business Division
Apr 1992: Joined the Company Apr 2010: General Manager, Sales and Development Department, Electronic Materials Business Division Jul 2015: Executive Officer; General Manager, Sales and Development Department, Life Science Business Division Apr 2019: General Manager, Life Science Business Division Jun 2019: Director (current) Apr 2024: General Manager, Electronic Materials Business Division (current) Apr 2026: General Manager, Electronic Materials Headquarters (current)
1968-11-11
Hiroyuki ITO
Director; General Manager, Administration Headquarters
Apr 1987: Joined The Daiwa Bank, Ltd. (now Resona Bank, Limited) May 1994: Seconded to IBJ International Plc Apr 1996: Seconded to Daiwa Bank Capital Management Plc Feb 2007: General Manager, Financial Products Compliance Office, Resona Bank, Limited Jul 2010: General Manager, Bay Area Sales Division I, Resona Bank, Limited Apr 2014: General Manager, Internal Audit Department, Resona Bank, Limited Apr 2017: Joined the Company; General Manager, General Affairs Department, Administration Headquarters Jul 2020: Executive Officer; General Manager, Administration Headquarters (current) Jul 2023: Senior Executive Officer Jun 2025: Director (current)
1964-10-15
Norikazu MIYAMOTO
Director; General Manager, Production Headquarters
Apr 1994: Joined the Company Apr 2015: General Manager, Kyoto Production Department, Electronic Materials Business Division Jun 2017: President, Qingdao Fuso Seisei Kako Co., Ltd. Jan 2020: General Manager, Production Headquarters, Life Science Business Division Jul 2020: Executive Officer Sep 2023: General Manager, Kashima Plant Apr 2024: Senior Executive Officer; General Manager, Production Headquarters (current) Jul 2024: General Manager, Kyoto Plant Jun 2025: Director (current)
1967-04-21
Kei MOMOSHIMA
Director
Apr 1981: Joined the Ministry of Finance Jul 1999: Director, Tax Investigation Department, Tokyo Regional Taxation Bureau Jul 2011: Deputy Director-General, Commissioner's Secretariat, National Tax Agency Jul 2012: Commissioner, Nagoya Regional Taxation Bureau Apr 2015: Executive Director, Japan Mint Apr 2018: Deputy Director-General, Minister's Secretariat, Ministry of Finance Apr 2019: Professor, Faculty of Business Administration, Otemon Gakuin University Apr 2019: Senior Visiting Fellow, Policy Research Institute, Ministry of Finance (current) Jun 2019: Outside Director, Osaka Soda Co., Ltd. (current) Oct 2019: Part-time Lecturer, Graduate School of Public Policy, Kyoto University Jun 2020: Outside Audit and Supervisory Board Member, Sumitomo Riko Company Limited Mar 2021: Councilor, Kyoto International Conference Hall Foundation (current) Jun 2022: Outside Director of the Company (current) Apr 2025: Specially Appointed Professor, Graduate School of Public Policy, Kyoto University (current) Apr 2025: Visiting Professor, Otemon Gakuin University (current)
1958-12-20
Fumiaki HIRATA
Director (Audit and Supervisory Committee Member)
Apr 1981: Joined Takeda Pharmaceutical Company Limited Jun 2006: Director and Director of Research Institute, Mitsui Chemicals Polyurethanes, Inc. (now Mitsui Chemicals, Inc.) Apr 2009: Executive Officer, Mitsui Chemicals, Inc. May 2012: Executive Officer and General Manager, Kashima Plant, Mitsui Chemicals, Inc. Apr 2016: President and Representative Director, MC Kogyo Co., Ltd. (now Mitsui MC Co., Ltd.) Mar 2021: Retired as Advisor, Mitsui MC Co., Ltd. Jun 2021: Outside Director (Audit and Supervisory Committee Member) of the Company (current)
1955-06-03
Takeshi TAKEUCHI
Director (Audit and Supervisory Committee Member)
Apr 1987: Joined Osaka Gas Co., Ltd. Apr 2016: Executive Officer; President and Representative Director, Osaka Gas Chemicals Co., Ltd. Apr 2018: Managing Executive Officer, Osaka Gas Co., Ltd. Jun 2019: Director and Managing Executive Officer, Osaka Gas Co., Ltd. Apr 2023: Advisor, Osaka Gas Co., Ltd. (current) Chairman of the Board, Osaka Gas Liquid Co., Ltd. (current) Jun 2023: Vice President, The Japan Boiler Society (current) Jul 2023: Chairman, Osaka International Science Club (current) Feb 2024: Director, The Japan Institute of Energy (current) Jun 2024: Outside Director (Audit and Supervisory Committee Member) of the Company (current) Jun 2025: Vice President, The Energy and Resources Society (current)
1961-07-28
Sayaka EGURO
Director (Audit and Supervisory Committee Member)
Dec 2008: Registered as attorney with Daiichi Tokyo Bar Association; joined Soga, Uryu & Itoga Law Offices Dec 2009: Seconded to the National Strategy Office, Cabinet Secretariat May 2012: Joined City-Yuwa Partners (current) Jun 2015: Outside Director of the Company Jun 2018: Outside Director (Audit and Supervisory Committee Member) of the Company Jun 2020: Retired as Outside Director (Audit and Supervisory Committee Member) of the Company Jun 2022: Outside Director (Audit and Supervisory Committee Member) of the Company (current) Outside Director, K.I Star Real Estate Co., Ltd.
1980-05-25
Toshihide TOMINAGA
Director (Audit and Supervisory Committee Member)
Apr 1980: Joined Matsushita Electric Industrial Co., Ltd. (now Panasonic Holdings Corporation) Jun 2007: Representative Director (CFO), Panasonic Communications Co., Ltd. (now Panasonic Connect Co., Ltd.) Jan 2014: President and Representative Director, Panasonic Precision Devices Co., Ltd. (now Panasonic Holdings Corporation) Aug 2015: Vice President, Panasonic Automotive & Industrial Systems Europe Ltd. (now Panasonic Industry Europe Ltd.) Jun 2016: President and Representative Director, Panasonic Device SUNX Co., Ltd. (now Panasonic Industry Co., Ltd.) Jun 2019: Standing Audit and Supervisory Board Member, Panasonic Corporation (now Panasonic Holdings Corporation) Mar 2024: Outside Director (Audit and Supervisory Committee Member), Taisho Pharmaceutical Co., Ltd. (current) Jun 2026: Outside Director (Audit and Supervisory Committee Member) of the Company (current)
1957-08-03
Large Shareholding Reports
Sumitomo Mitsui DS Asset Management Company, Limited
2026-03-23
5.14%→6.15%
Sumitomo Mitsui DS Asset Management Company, Limited
2026-02-06
5.14%
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-08-07
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-19
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2026-03-23
Large Shareholding Report
TDnet
2026-02-06
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2026-02-06
Large Shareholding Report
EDINET
2025-11-07
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2025-08-08
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-19
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-07
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-08
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-07
Q1 Earnings Flash
FY ending Mar 2025
EDINETAmended
2024-07-12
Amended Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-06-24
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-09
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-10
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-10
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINETAmended
2023-07-28
Amended Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-06-26
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-10
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-14
Quarterly Securities Report
EDINET
2022-08-10
Quarterly Securities Report
EDINET
2022-06-27
Annual Securities Report
EDINET
2022-02-10
Quarterly Securities Report
EDINET
2021-11-10
Quarterly Securities Report
EDINET
2021-08-10
Quarterly Securities Report
EDINETAmended
2021-07-26
Amended Annual Securities Report
EDINET
2021-06-28
Annual Securities Report
EDINET
2021-02-10
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →